| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.17 | 0.6 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |